Body1 and Straumann Launch Online Consumer Resource to Expand Awareness of Dental Options; Dental1.org Debuts for Consumers Seeking to ''Up Their Dental I.Q.''

Body1 and Straumann Launch Online Consumer Resource to Expand Awareness of Dental Options; Dental1.org Debuts for Consumers Seeking to 'Up Their Dental I.Q.'
February 1, 2005
Body1.com
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 1, 2005--Body1, Inc and Straumann USA, Inc announced the launch of http://www.Dental1.org (Dental1). Dental1 is a "knowledge community" (or "KnowCo") site for patients seeking information on oral health and the latest technological improvements in dental treatment. The launch of http://www.Dental1.org provides patients with comprehensive resources to expand their awareness of industry-leading oral health technology such as implants. Part of the Body1 network of health awareness sites, Dental1.org will present timely news features, reference material including procedures, self diagnosis, and searchable conditions. Visitors will participate in focused threaded discussion and live chats with oral health care specialists.
This alliance creates an independent, Internet-based channel that Straumann is supporting in order to provide educational information about new medical technologies for tissue regeneration and implants as an option for replacing missing teeth. This sponsored educational program highlights Straumann's recent advances in oral health on behalf of patients and referring dentists.
"Body1 has an outstanding reputation for providing the public education on health and medicine and we are excited about our collaboration through this project. We look forward to raising the public's awareness of dental implants as a standard of care for tooth replacement and the many benefits that implant treatment offers over other conventional methods," said Russ Olsen, President of Straumann USA, Inc. "We are delighted to work with such an important leader in oral technologies for patient care such as Straumann," said Chris Messina, CEO of Body1, Inc. "We believe that they have all the ingredients for advancing the state of art in oral health care - the vision, the people, and the products."
About Body1, Inc
Body1, Inc. educates targeted populations on behalf of medical product manufacturers through its network of knowledge communities, or "KnowCos" such as www.Heart1.com, www.Reflux1.com, and www.Knee1.com. In addition to patient education, Body1 provides interactive, knowledge-based tools for online medical education programs (the eForums suite). It also provides accredited physicians with complementary web sites through http://www.Doctors1.org. Body1's programs all accelerate the adoption of innovations that enhance human health.
The Body1 Network is one of the most visited online health networks with over 4 million visits per year and is accredited by the Health on the Net (HON) Foundation.
About Straumann:
Headquartered in Basel, Switzerland, Straumann (SWX: STMN) is a global leader in implant dentistry and dental tissue regeneration. In collaboration with the International Team for Implantology (ITI), leading clinics, research institutes and universities, Straumann researches, develops, produces and distributes implants, instruments and tissue regeneration products for use in tooth replacement solutions or to prevent tooth loss. They continue to provide training and services to dental professionals worldwide with their Newport Beach, CA training facility and the much-anticipated opening of the new state-of-the-art training facility in Andover, MA. The Straumann US office, currently located in Waltham, MA, is planning to venture to Andover this spring to begin US manufacturing and prepare for further expansion. In the past, Straumann's implants and instruments have been manufactured in Switzerland alone, whilst its dental tissue regeneration products are produced in Sweden. With affiliates in 14 countries and distributors in 35, Straumann employs more than 1000 people worldwide. In 2003, the Group generated sales of CHF 344 million and a net income of CHF 80 million.